Coherus Oncology Inc (CHRS)

P/OCF Ratio

-0.65×

TTM · Retrieved:

CHRS logo

CHRS P/OCF Ratio

Current (TTM)-0.65×
CHRS Quarterly P/OCF Ratio (-5.05× → -1.81×)
High-resolution chart · PNG

CHRS p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-1.8066×
-3.9822×
-8.6693×
-4.1135×
-1.8204×
-3.6203×
5.5676×
-1.9321×
3.0947×
-5.7862×
-28.6983×
-6.7319×
-9.5758×
-7.8886×
-6.177×
-20.1447×
-11.1636×
-18.454×
-23.2893×
92.1567×
-5,558.4607×
778.4122×
37.8956×
27.7501×
21.0969×
85.0442×
71.3778×
25.7634×
123.4257×
-15.8579×
-13.0032×
-25.6866×
-25.2026×
-19.7817×
-17.1588×
-17.3884×
-13.2443×
-14.0598×
-14.3565×
-18.792×
-25.0975×
-10.8759×
160.5832×
-12.8835×
-52.2429×
-30.8716×
-9.7286×
-32.0375×
-1,050.8538×
15.4653×
45.7351×
10.5935×
-9.7275×
-5.0481×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.